Drugs / H02
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05040906 | Oct 2020 → Oct 2023 | — | Shandong New Time Pharmaceutical Co., LTD | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | H02 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05040906 ↗ |